Product Information
ATORVASTATIN 20 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0276 per EA under NDC 00378395177. Its NADAC has been published 664 times since Dec 5, 2013.
FDA first approved this application on May 29, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378395177
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA091226FDA Approved
5/29/2012
TE Code
AB
On Market Since
9/19/2013
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 20 MG TABLET has been published 664 times since Dec 5, 2013, and over the history we have for it it has declined 84.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0276 per EA |
|---|---|
| All-time high | $0.1827 (Dec 11, 2013) |
| All-time low | $0.0276 (Aug 19, 2026) |
| 52-week high | $0.0336 |
| 52-week low | $0.0276 |
| Median price | $0.0715 |
| Average price | $0.0799 |
| Largest weekly change | +32.4% (Aug 21, 2024) |
| Weeks tracked | 664 |
| Tracking since | Dec 5, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATORVASTATIN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 20 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0276 per EA (NDC 00378395177), effective Aug 19, 2026.
How has the price of ATORVASTATIN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 20 MG TABLET has declined 84.9%. It has been tracked across 664 weekly CMS publications since Dec 5, 2013.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 20 MG TABLET?
Since Dec 5, 2013, the NADAC for ATORVASTATIN 20 MG TABLET has ranged from a low of $0.0276 (Aug 19, 2026) to a high of $0.1827 (Dec 11, 2013), with a median of $0.0715 per EA.
Are there cheaper alternatives to ATORVASTATIN 20 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATORVASTATIN 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ATORVASTATIN 20 MG TABLET?
ATORVASTATIN 20 MG TABLET (NDC 00378395177) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.